Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18495692

Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer

Author
BELANI, C. P1 ; DAKHIL, S2 ; WATERHOUSE, D. M3 ; DESCH, C. E4 ; ROONEY, D. K5 ; GLARK, R. H6 ; MONBERG, M. J7 ; YE, Z7 ; OBASAJU, C. K7
[1] University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States
[2] Cancer Center of Kansas, P.A, Wichita, KS, United States
[3] The Jewish Hospital-Kenwood, Cincinnati, OH, United States
[4] Hematology and Oncology of Virginia, Richmond, VA, United States
[5] Hematology/Oncology, Inc, Canton, OH, United States
[6] Hematology/Oncology Associates, Jackson, MI, United States
[7] Lilly Research Laboratories, Indianapolis, IN, United States
Source

Annals of oncology. 2007, Vol 18, Num 1, pp 110-115, 6 p ; ref : 34 ref

ISSN
0923-7534
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Oxford University Press, Oxford
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
gemcitabine non-platinum doublets non-small-cell lung cancer paclitaxel
Keyword (fr)
Anticancéreux Cancer du poumon Carcinome non petite cellule bronchopulmonaire Essai clinique phase II Essai clinique Etude comparative Gemcitabine Homme Paclitaxel Platine Randomisation Stade avancé Antimitotique Antimétabolite Appareil respiratoire pathologie Bronche pathologie Fluor Composé organique Poumon pathologie Pyrimidine dérivé Pyrimidine nucléoside Taxane dérivé Tumeur maligne
Keyword (en)
Antineoplastic agent Lung cancer non-small cell lung carcinoma Phase II trial Clinical trial Comparative study Gemcitabine Human Paclitaxel Platinum Randomization Advanced stage Antimitotic Antimetabolic Respiratory disease Bronchus disease Fluorine Organic compounds Lung disease Pyrimidine derivatives Pyrimidine nucleoside Taxane derivatives Malignant tumor
Keyword (es)
Anticanceroso Cáncer del pulmón Carcinoma no pequeňa célula bronchopulmonar Ensayo clínico fase II Ensayo clínico Estudio comparativo Gemcitabina Hombre Paclitaxel Platino Aleatorización Estadio avanzado Antimitótico Antimetabólito Aparato respiratorio patología Bronquio patología Fluor Compuesto orgánico Pulmón patología Pirimidina derivado Pirimidina nucleósido Taxane derivado Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum

Discipline
Pharmacological treatments Pulmonology
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18495692

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web